{"id":6009,"date":"2022-04-14T09:06:02","date_gmt":"2022-04-14T07:06:02","guid":{"rendered":"https:\/\/www.rapharm.eu\/en\/?p=6009"},"modified":"2022-04-19T14:43:19","modified_gmt":"2022-04-19T12:43:19","slug":"eu-expert-panels-on-medical-devices-and-in-vitro-diagnostics-transferred-to-european-medicines-agency-ema","status":"publish","type":"post","link":"https:\/\/www.rapharm.eu\/en\/eu-expert-panels-on-medical-devices-and-in-vitro-diagnostics-transferred-to-european-medicines-agency-ema\/","title":{"rendered":"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA)"},"content":{"rendered":"<style type=\"text\/css\"><\/style>\n<p>On 1 March, the Secretariat of the\nCommission\u2019s expert panels on medical devices and <em>in vitro<\/em> diagnostic\nmedical devices has been handed over from the Joint Research Centre (JRC) to\nthe European Medicines Agency (EMA). <\/p>\n\n\n\n<p>The JRC had been\nentrusted by DG Health and Food Safety (DG SANTE) to establish the panels,\ndefine guidance documents, operational workflows, and necessary IT tools as\nwell as to launch their mandatory advisory functions. <\/p>\n\n\n\n<p>The background of the handover is the\nextended mandate of EMA on crisis preparedness and management of medicinal\nproducts and medical devices (Regulation (EU) 2022\/123), developed as a\nreaction to the COVID-19 pandemic in the EU.<\/p>\n\n\n\n<p>Click <a href=\"https:\/\/t19a9129c.emailsys2a.net\/c\/175\/5190201\/4329\/0\/21309371\/48461\/312401\/94e6172f36.html\">here <\/a>for more\ninformation.&nbsp;<\/p>\n\n\n\n<p><strong>Do you need additional knowledge or assistance in\nmeeting the requirements of MDR\/IVDR?<\/strong><\/p>\n\n\n\n<p>With the help of our <a href=\"https:\/\/www.rapharm.eu\/en\/actual-educations\/\">Actual\neducations<\/a> and <a href=\"https:\/\/www.rapharm.eu\/en\/consulting-services\/\">consulting services<\/a>, we can help you meet the requirements of the MDR\/IVDR.<\/p>\n\n\n\n<p><strong>Resource:<\/strong><\/p>\n\n\n\n<p><a href=\"https:\/\/ec.europa.eu\/health\/system\/files\/2022-03\/md_handover-panels_en_1.pdf\">Handover of expert panels on medical devices and in vitro diagnostics\nfrom the Commission\u2019s Joint Research Centre (JRC) to the European Medicines\nAgency (EMA)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>On 1 March, the Secretariat of the Commission\u2019s expert panels on medical devices and in vitro diagnostic medical devices has been handed over from the Joint Research Centre (JRC) to the European Medicines Agency (EMA). The JRC had been entrusted by DG Health and Food Safety (DG SANTE) to establish the panels, define guidance documents,&#8230;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[45],"tags":[],"class_list":["post-6009","post","type-post","status-publish","format-standard","hentry","category-novice-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA) - raPHARM<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA) - raPHARM\" \/>\n<meta property=\"og:description\" content=\"On 1 March, the Secretariat of the Commission\u2019s expert panels on medical devices and in vitro diagnostic medical devices has been handed over from the Joint Research Centre (JRC) to the European Medicines Agency (EMA). The JRC had been entrusted by DG Health and Food Safety (DG SANTE) to establish the panels, define guidance documents,...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\" \/>\n<meta property=\"og:site_name\" content=\"raPHARM\" \/>\n<meta property=\"article:published_time\" content=\"2022-04-14T07:06:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-04-19T12:43:19+00:00\" \/>\n<meta name=\"author\" content=\"rapharm\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"rapharm\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\",\"url\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\",\"name\":\"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA) - raPHARM\",\"isPartOf\":{\"@id\":\"https:\/\/www.rapharm.eu\/#website\"},\"datePublished\":\"2022-04-14T07:06:02+00:00\",\"dateModified\":\"2022-04-19T12:43:19+00:00\",\"author\":{\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.rapharm.eu\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.rapharm.eu\/#website\",\"url\":\"https:\/\/www.rapharm.eu\/\",\"name\":\"raPHARM\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.rapharm.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1\",\"name\":\"rapharm\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g\",\"caption\":\"rapharm\"},\"url\":\"https:\/\/www.rapharm.eu\/en\/author\/rapharm\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA) - raPHARM","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","og_locale":"en_US","og_type":"article","og_title":"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA) - raPHARM","og_description":"On 1 March, the Secretariat of the Commission\u2019s expert panels on medical devices and in vitro diagnostic medical devices has been handed over from the Joint Research Centre (JRC) to the European Medicines Agency (EMA). The JRC had been entrusted by DG Health and Food Safety (DG SANTE) to establish the panels, define guidance documents,...","og_url":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","og_site_name":"raPHARM","article_published_time":"2022-04-14T07:06:02+00:00","article_modified_time":"2022-04-19T12:43:19+00:00","author":"rapharm","twitter_card":"summary_large_image","twitter_misc":{"Written by":"rapharm","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","url":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/","name":"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA) - raPHARM","isPartOf":{"@id":"https:\/\/www.rapharm.eu\/#website"},"datePublished":"2022-04-14T07:06:02+00:00","dateModified":"2022-04-19T12:43:19+00:00","author":{"@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1"},"breadcrumb":{"@id":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rapharm.eu\/eu-strokovni-odbori-za-medicinske-pripomocke-in-in-vitro-diagnosticne-medicinske-pripomocke-so-bili-preneseni-na-evropsko-agencijo-za-zdravila-ema\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rapharm.eu\/en\/"},{"@type":"ListItem","position":2,"name":"EU: Expert Panels on medical devices and in vitro diagnostics transferred to European Medicines Agency (EMA)"}]},{"@type":"WebSite","@id":"https:\/\/www.rapharm.eu\/#website","url":"https:\/\/www.rapharm.eu\/","name":"raPHARM","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rapharm.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/ba2051c1c51d2328945ac838b3f1d7e1","name":"rapharm","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rapharm.eu\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9ea8e299db6979b3c68307fd37c34f245020d4996bcf2ccdeec4bce3350fcc24?s=96&d=mm&r=g","caption":"rapharm"},"url":"https:\/\/www.rapharm.eu\/en\/author\/rapharm\/"}]}},"_links":{"self":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/6009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/comments?post=6009"}],"version-history":[{"count":1,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/6009\/revisions"}],"predecessor-version":[{"id":6010,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/posts\/6009\/revisions\/6010"}],"wp:attachment":[{"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/media?parent=6009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/categories?post=6009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rapharm.eu\/en\/wp-json\/wp\/v2\/tags?post=6009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}